In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

Big updates in obesity treatment, a closer look at pandemic death counts and a disease that takes a decade to diagnose are among today's Daily Dose.

Broad generic availability of semaglutide is not expected until the early 2030s, which means most Americans will stay on branded Ozempic and Wegovy for years to come. Some patients may eye Canadian ...

The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this ...

As geopolitical uncertainties persist, the possibility of a Canadian-made version of one of the most popular drugs in the ...

WINNIPEG, MB - March 05, 2026 - PRESSADVANTAGE - BuyCanadianInsulin.com reports that generic semaglutide may become ...

Aspen Pharmacare, a South African drugmaker, plans to enter the Canadian market with a generic version of Novo Nordisk’s blockbuster diabetes and weight-loss drug Ozempic by the third quarter of 2026.

(Reuters) -Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and heart-related deaths in type-2 diabetes ...

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

Health Canada is warning Canadians about counterfeit versions of popular diabetes and weight-loss drugs, including Ozempic and Mounjaro, amid rising reports of unsafe products being sold online and in ...

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.